Seedcamp

"We urgently need more people contributing to medical science, but the gap between those wanting to take part and actually knowing how to is huge. The scientific community has long relied on time-starved doctors signposting patients to clinical trials which just isn’t an effective way to get decent levels of participation. The pandemic has added further challenges, as many patients with rare and chronic diseases are unable to safely leave home."

"The events of the past year have made workplace mental health issues front of mind for many, but these are problems which have long needed solving. It’s vital that, in today’s knowledge-driven economy, workers have access to high-quality mental health support that’s barrier-free, stigma-free, and free at the point of use. And that’s exactly what Spill will be able to deliver dramatically more of with the help of this latest funding round, led by Ada Ventures. We’re excited to help more companies create environments where people feel secure, engaged, and fundamentally understood — which is not only the humane thing to do for the team, but it’s the smart thing to do for the business. "

"While working as a doctor, I saw firsthand the devastating complications of type 2 diabetes – from strokes to heart attacks to blindness. For the majority of patients, pills are not solving the problem. We now have strong clinical evidence that remission can be the goal for most patients. Sadly, with the NHS at a breaking point, it is not in a place to deliver intensive remission programs to the 4.2 million type 2 diabetics in the UK."

"Weavr’s solution provided us with the platform to accelerate our route to market. We were faced with developing multiple integrations across many third-party stakeholders. Working with Weavr removed the need to carry out a long and complex build and meant we could take advantage of favourable market forces that we may have otherwise missed."